Technical Analysis: 5 Cannabis Stocks
Konstantin Kaiser | Feb 15, 2019 09:55AM ET
Tilray (NASDAQ:TLRY)
Weekly Chart – Chart created with Tradingview
Canadian cannabis producer Tilray was rejected by the resistance at $100 and formed a series of higher lows since then. Due to the fact that the trendline resistance was broken, it turned into a support which successfully held. The trendline support of the falling wedge pattern, which is around $60, acts as additional support.
Aurora Cannabis (TO:ACB)
Weekly Chart – Chart created with Tradingview
Aurora successfully bounced off the support at around $5 and rose all the way up to the $8 mark, where it then faced rejection by the resistance. The steady increase in volume during the sideways movement is a bullish sign. Due to a bearish divergence in the daily RSI, it seems very likely that a correction wave will take place. Aurora will most likely decline to the golden pocket zone at $6. Assuming bullishness, a bounce off this mark and a continuation of the uptrend is likely. If it does not bounce, it will find its next support at around $5.
Canopy Growth Corporation (NYSE:CGC)
Weekly Chart – Chart created with Tradingview
Canopy surged incredibly since my last analysis and shelters an amazing trading opportunity right now. Canopy will most likely decline to the support range at $14, which happens to be located at the golden pocket zone and, simultaneously, at the 2.5-year long trendline support. It is likely that the support between $12.5 and $14 will hold and result in a continuation of the uptrend. If not, the next support will be found at around $9.
Get The News You Want
Cronos Group (NASDAQ:CRON)
Weekly Chart – Chart created with Tradingview
Cronos is giving us a very similar setup. While the volume increased tremendously throughout the end of 2018 and the beginning of 2019, it seems likely that a small correction wave will take place. Cronos will most likely bounce off the golden pocket zone located at the support ranging from $34 to $38 where the 2.5-year trendline acts as additional, major support. If the triple-support fails to hold, the bullish setup is denied and Cronos will most likely decline to its next support at around $25.
GW Pharmaceuticals PLC ADR (NASDAQ:GWPH)
Weekly Chart – Chart created with Tradingview
GW Pharmaceuticals broke the resistance at $137 which now acts as support. After being rejected by the resistance at around $150, GW Pharmaceuticals quickly bounced off the newly established support at $137. That being said, it is ranging between support and resistance, which is a quite neutral setup.
The S&P 500 index surged by 13 percent since the beginning of the year whereas Cronos rose by an incredible 160 percent.
Moreover, at the time of writing, and according to the global market capitalization on Coinmarketcap, Bitcoin is currently located at around $3,600.
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.